Sabby Management’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-4,950
Closed -$10M 167
2017
Q4
$10M Sell
4,950
-8,087
-62% -$149K 0.91% 21
2017
Q3
$22.6M Buy
13,037
+6,170
+90% +$83.6K 1.48% 15
2017
Q2
$8.8M Buy
6,867
+3,619
+111% +$48.3K 0.58% 26
2017
Q1
$4.21M Buy
3,248
+540
+20% +$6.83K 0.23% 55
2016
Q4
$2.68M Sell
2,708
-2,193
-45% -$24K 0.16% 83
2016
Q3
$5.92M Buy
4,901
+2,800
+133% +$28.6K 0.22% 69
2016
Q2
$1.81M Buy
2,101
+72
+4% +$711 0.09% 117
2016
Q1
$1.92M Sell
2,029
-1,985
-49% -$18.7K 0.1% 100
2015
Q4
$6.96M Hold
4,014
0.38% 46
2015
Q3
$5.39M Hold
4,014
0.22% 77
2015
Q2
$9.06M Buy
4,014
+512
+15% +$9K 0.33% 66
2015
Q1
$5M Buy
+3,502
New +$50.5K 0.21% 77
2014
Q1
Sell
-700
Closed -$1.05M 255
2013
Q4
$1.05M Buy
+700
New +$9K 0.07% 115

Other funds holding HALO

Sabby Management's HALO Position: Q2 2018 in Review

Sabby Management sold out of Halozyme (HALO) in Q2 2018, closing a stake of 102 shares — an estimated $2K sold.

Sabby Management first reported a position in HALO in Q1 2015 and held it in 3 quarters. The position peaked at $2.74M in Q1 2015. 193 funds tracked by Wall St. Rank hold HALO as of Q2 2018.

  • Sabby Management reported no remaining Halozyme position as of Q2 2018 after selling out during the quarter.
  • Sabby Management sold 102 Halozyme shares in Q2 2018, an estimated $2K.
  • Sabby Management first reported a position in Halozyme in Q1 2015 and held it in 3 quarters.
  • Sabby Management's Halozyme position peaked at $2.74M in Q1 2015.
  • 193 funds tracked by Wall St. Rank held Halozyme as of Q2 2018.

Based on Sabby Management's 13F filing for Q2 2018, filed 14 Aug 2018.